ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025
Association of biological age acceleration with poor outcome after endovascular thrombectomy.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccelerated aging is recognized as a risk factor for various chronic diseases and mortality. This study aimed to utilize phenotypic age to evaluate the role of biological age in clinical outcomes in ischemic stroke patients after endovascular thrombectomy (EVT).
methodsWe retrospectively enrolled patients from the prospectively maintained stroke registry admitted at 2 stroke centers in China. We employed the widely recognized PhenoAge algorithms to calculate accelerated biological age. Poor outcome was defined by a modified Rankin Scale score > 2 at 90 days post-treatment. Multivariable logistic regression models were utilized to evaluate the independent impact of phenotypic age on poor outcome. The association pattern between phenotypic age and poor outcome were analyzed using restricted cubic splines.
resultsA total of 745 patients were included with 61.5% male, a mean age of 70.1 ± 12.2 years, and a mean phenotypic age of 78.5 ± 15.1 years. In the multivariable logistic regression analysis, phenotypic age was significantly associated with 90-day poor outcome after EVT (per 1-year increase: odds ratio [OR], 1.067; 95% confidence interval [CI], 1.042-1.092; P < 0.001; fourth vs first quartile: OR, 8.295; 95% CI, 3.742-18.394; P < 0.001). Additionally, the multiple-adjusted spline regression model further confirmed the dose-response association between phenotypic age and poor outcome (P = 0.527 for nonlinearity; P = 0.001 for linearity).
conclusionThis study demonstrated that phenotypic age was associated with poor outcomes in large vessel occlusive stroke patients treated with EVT. Further research is required to validate our findings in different populations.
Indexed as
Identifiers
40439830What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.